Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
iShares iBonds Dec 2031 Term Treasury ETF
IBTL
$656M
| $1.67M | ﹤0.01% |
81,133
+20,223
| +33% | +$400K |
|
3152
Omeros
OMER
$1.24B
| $1.66M | ﹤0.01% |
508,940
-1,546,959
| -75% | -$3.27M |
|
|
PDCO
3153
DELISTED
Patterson Companies, Inc.
PDCO
| $1.66M | ﹤0.01% |
58,389
+14,373
| +33% | +$423K |
|
3154
Xenon Pharmaceuticals
XENE
$6.03B
| $1.66M | ﹤0.01% |
36,055
+8,934
| +33% | +$316K |
|
3155
Dimensional US Core Equity 1 ETF
DCOR
$3.48B
| $1.66M | ﹤0.01% |
+31,046
| New | +$1.54M |
|
|
CTR
3156
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
| $1.66M | ﹤0.01% |
45,760
+11
| +0% | +$360 |
|
|
HTD
3157
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$904M
| $1.65M | ﹤0.01% |
87,075
-5,531
| -6% | -$98K |
|
3158
CALL
iShares MSCI Canada ETF
EWC
$6.56B
| $1.65M | ﹤0.01% |
45,000
-2,755,000
| -98% | -$93.9M |
|
3159
Invesco MSCI Sustainable Future ETF
ERTH
$138M
| $1.65M | ﹤0.01% |
34,863
-18,034
| -34% | -$769K |
|
3160
Evolent Health
EVH
$529M
| $1.64M | ﹤0.01% |
49,604
+21,807
| +78% | +$617K |
|
3161
Nuveen California Municipal Value Fund
NCA
$303M
| $1.64M | ﹤0.01% |
182,545
+1,946
| +1% | +$16.3K |
|
3162
CALL
NIO
NIO
$11.3B
| $1.63M | ﹤0.01% |
180,000
+50,000
| +38% | +$397K |
|
3163
Hovnanian Enterprises
HOV
$785M
| $1.63M | ﹤0.01% |
10,482
-1,342
| -11% | -$135K |
|
3164
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $1.63M | ﹤0.01% |
64,861
+4,828
| +8% | +$118K |
|
|
GTY
3165
Getty Realty Corp
GTY
$2.05B
| $1.63M | ﹤0.01% |
55,821
+7,436
| +15% | +$211K |
|
3166
Matsons
MATX
$6.5B
| $1.63M | ﹤0.01% |
14,850
+6,068
| +69% | +$576K |
|
3167
Rentokil
RTO
$12B
| $1.63M | ﹤0.01% |
56,959
+2,267
| +4% | +$66.6K |
|
3168
Uranium Energy
UEC
$5.55B
| $1.63M | ﹤0.01% |
254,215
+45,339
| +22% | +$270K |
|
|
BFS
3169
Saul Centers
BFS
$860M
| $1.63M | ﹤0.01% |
41,400
+1,310
| +3% | +$48K |
|
3170
Mercer International
MERC
$31.6M
| $1.63M | ﹤0.01% |
171,429
+6,152
| +4% | +$55.2K |
|
3171
Warrior Met Coal
HCC
$5.19B
| $1.62M | ﹤0.01% |
26,625
+5,163
| +24% | +$272K |
|
3172
DLH Holdings
DLHC
$67.5M
| $1.62M | ﹤0.01% |
103,054
-1,219
| -1% | -$17.1K |
|
3173
MoonLake Immunotherapeutics
MLTX
$1.4B
| $1.62M | ﹤0.01% |
26,788
+2,705
| +11% | +$139K |
|
3174
Innovative Industrial Properties
IIPR
$1.62B
| $1.62M | ﹤0.01% |
16,039
+3,534
| +28% | +$290K |
|
3175
Caribou Biosciences
CRBU
$169M
| $1.62M | ﹤0.01% |
281,937
+249,997
| +783% | +$1.24M |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 467 new positions and adding to 4,112 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 467 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.